)
Visual
test
Atara Biotherapeutics
Atara Biotherapeutics (ATRA) investor relations material
Atara Biotherapeutics Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration Filing summary17 Mar, 2026
Company overview and business model
Focuses on T-cell immunotherapy, leveraging an allogeneic Epstein-Barr virus T-cell platform for cancer and autoimmune disease therapies.
Lead product, tab-cel® (tabelecleucel), has received marketing authorization in Europe, the UK, and Switzerland, and is in Phase 3 development in the U.S.
Commercialization partnership with Pierre Fabre Medicament for tab-cel in Europe and potentially worldwide.
Incorporated in Delaware in 2012, headquartered in Thousand Oaks, California.
Financial performance and metrics
Qualifies as a "smaller reporting company" with market value of public float and annual revenue below SEC thresholds.
Provides only two years of audited financial statements and reduced executive compensation disclosures.
Use of proceeds and capital allocation
Will not receive proceeds from the resale of shares by the selling stockholder.
May receive proceeds from warrant exercise, intended for working capital and general corporate purposes.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Atara Biotherapeutics
- Returned to profitability in 2025 with a strengthened cash position and reduced expenses.ATRA
Q4 202516 Mar 2026 - Allogeneic CAR T therapies advance toward US approval and global commercialization milestones.ATRAH.C. Wainwright 26th Annual Global Investment Conference 202414 Mar 2026
- All proposals passed, including director elections and auditor ratification, with no questions raised.ATRAAGM 20253 Feb 2026
- Allogeneic T-cell therapies advance in oncology and autoimmune disease, with US launch set for 2025.ATRAStifel's 2024 Virtual Cell Therapy Forum3 Feb 2026
- Allogeneic T-cell platform advances with key clinical milestones and strong financial runway.ATRASidoti Micro-Cap Virtual Conference2 Feb 2026
- First-in-class allogeneic T-cell therapy advances toward U.S. approval and clinical expansion.ATRACanaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026
- All proposals except the automatic equity plan increase were approved at the annual meeting.ATRAAGM 20241 Feb 2026
- Allogeneic EBV T cell therapies advance in oncology and autoimmunity, with global milestones ahead.ATRAGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026
- Allogeneic CAR-T platform advances with Tab-cel U.S. review and robust pipeline in oncology and autoimmunity.ATRA17th Annual LD Micro Main Event Conference17 Jan 2026
Next Atara Biotherapeutics earnings date
Q1 202613 May, 2026
Atara Biotherapeutics
Next Atara Biotherapeutics earnings date
Q1 202613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage